Usana Health Sciences Inc logo

Usana Health Sciences Inc

$ 72.19 -0.24 (-0.33%) 11:09 PM EST
On watch
P/E:
15.88
P/B:
3.45
Market Cap:
$ 1.39B
Enterprise V:
$ 1.16B
Volume:
39.01K
Avg Vol (2M):
78.70K
Also Trade In:
Volume:
39.01K
Market Cap $:
1.39B
PE Ratio:
15.88
Avg Vol (2-Month):
78.70K
Enterprise Value $:
1.16B
PB Ratio:
3.45
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Usana Health Sciences Inc
NAICS : 311999 SIC : 2021
3838 West Parkway Boulevard, Salt Lake City, UT, USA, 84120
Description
Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe, with the majority of its revenue generated from markets outside the United States.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.72
Interest Coverage 821.39
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 9.5
Distress
Grey
Safe
Beneish M-Score -2.58
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 71.99
9-Day RSI 63.61
14-Day RSI 58.23
6-1 Month Momentum % -24.58
12-1 Month Momentum % -29.51

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.56
Quick Ratio 1.93
Cash Ratio 1.72
Days Inventory 166.63
Days Payable 22.09

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 6.3

Financials (Next Earnings Date:2022-10-26 Est.)

USNA's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NYSE:USNA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1,078.992
EPS (TTM) ($) 4.54
Beta 0.82
Volatility % 17.62
14-Day RSI 58.23
14-Day ATR ($) 2.070936
20-Day SMA ($) 69.7975
12-1 Month Momentum % -29.51
52-Week Range ($) 63.49 - 103.95
Shares Outstanding (Mil) 19.2

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Usana Health Sciences Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More